128 related articles for article (PubMed ID: 10395017)
21. Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA.
Goldstone AP; Morgan I; Mercer JG; Morgan DG; Moar KM; Ghatei MA; Bloom SR
Biochem Biophys Res Commun; 2000 Mar; 269(2):331-5. PubMed ID: 10708552
[TBL] [Abstract][Full Text] [Related]
22. Estradiol increases catecholamine levels in the hypothalamus of ovariectomized rats during the dark-phase.
Alfinito PD; Chen X; Mastroeni R; Pawlyk AC; Deecher DC
Eur J Pharmacol; 2009 Aug; 616(1-3):334-9. PubMed ID: 19576879
[TBL] [Abstract][Full Text] [Related]
23. Effects of leptin on hypothalamic arcuate neurons in Wistar and Zucker rats: an in vitro study.
Nagamori K; Ishibashi M; Shiraishi T; Oomura Y; Sasaki K
Exp Biol Med (Maywood); 2003 Nov; 228(10):1162-7. PubMed ID: 14610255
[TBL] [Abstract][Full Text] [Related]
24. Endobain E, a brain Na+, K+ -ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus.
Vatta M; Peña C; Fernández BE; Rodríguez de Lores Arnaiz G
Life Sci; 2004 Dec; 76(4):359-65. PubMed ID: 15530498
[TBL] [Abstract][Full Text] [Related]
25. Preferential uptake of norepinephrine into dopaminergic terminals of a synaptosomal preparation from rat cerebral cortex.
Michel M; Hiemke C; Ghraf R
Brain Res; 1984 May; 301(1):149-52. PubMed ID: 6329439
[TBL] [Abstract][Full Text] [Related]
26. Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.
Ladyman SR; Augustine RA; Scherf E; Phillipps HR; Brown CH; Grattan DR
J Physiol; 2016 Feb; 594(4):1087-101. PubMed ID: 26613967
[TBL] [Abstract][Full Text] [Related]
27. Leptin sensitivity in the developing rat hypothalamus.
Carlo AS; Pyrski M; Loudes C; Faivre-Baumann A; Epelbaum J; Williams LM; Meyerhof W
Endocrinology; 2007 Dec; 148(12):6073-82. PubMed ID: 17872366
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic neuronal histamine as a target of leptin in feeding behavior.
Yoshimatsu H; Itateyama E; Kondou S; Tajima D; Himeno K; Hidaka S; Kurokawa M; Sakata T
Diabetes; 1999 Dec; 48(12):2286-91. PubMed ID: 10580415
[TBL] [Abstract][Full Text] [Related]
29. Central suppressive effect of octreotide on the hyperglycemic response to 2-deoxy-D-glucose injection or cold-swim stress in awake rats: possible mediation role of hypothalamic noradrenergic drive.
Gotoh M; Iguchi A; Kakumu S; Hirooka Y; Smythe GA
Brain Res; 2001 Mar; 895(1-2):146-52. PubMed ID: 11259771
[TBL] [Abstract][Full Text] [Related]
30. Changes in hypothalamic neurotransmitter uptake following pinealectomy, superior cervical ganglionectomy or melatonin administration to rats.
Cardinali DP
Neuroendocrinology; 1975; 19(1):91-5. PubMed ID: 1692
[TBL] [Abstract][Full Text] [Related]
31. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
Brunetti L; Ferrante C; Orlando G; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Mollica A; Vacca M
Peptides; 2013 Oct; 48():83-8. PubMed ID: 23916912
[TBL] [Abstract][Full Text] [Related]
32. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.
Reuben M; Boye S; Clarke PB
Eur J Pharmacol; 2000 Mar; 393(1-3):39-49. PubMed ID: 10770996
[TBL] [Abstract][Full Text] [Related]
33. Leptin accumulation in hypothalamic and dorsal raphe neurons is inversely correlated with brain serotonin content.
Fernández-Galaz MC; Fernández-Agulló T; Carrascosa JM; Ros M; Garcia-Segura LM
Brain Res; 2010 May; 1329():194-202. PubMed ID: 20211152
[TBL] [Abstract][Full Text] [Related]
34. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
Taglialatela M; Amoroso S; Kaparos G; Maurano F; Di Renzo GF; Annunziato L
J Pharmacol Exp Ther; 1988 Aug; 246(2):682-8. PubMed ID: 2457079
[TBL] [Abstract][Full Text] [Related]
35. Differential responsiveness of central noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy, ACTH and glucocorticoid administration.
Van Loon GR; Sole MJ; Kamble A; Kim C; Green S
Ann N Y Acad Sci; 1977 Oct; 297():284-94. PubMed ID: 29550
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat.
Seilicovich A; Lasaga M; Befumo M; Duvilanski BH; del Carmen Diaz M; Rettori V; McCann SM
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11299-302. PubMed ID: 7479983
[TBL] [Abstract][Full Text] [Related]
37. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
Uehara Y; Shimizu H; Ohtani K; Sato N; Mori M
Diabetes; 1998 Jun; 47(6):890-3. PubMed ID: 9604864
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the existence of stereoselective presynaptic beta 1-adrenoceptors on noradrenergic and dopaminergic neurons in the rat hypothalamus.
Chang CC; Goshima Y; Misu Y
Jpn J Pharmacol; 1986 Nov; 42(3):447-9. PubMed ID: 3029487
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic control of FSH and LH by FSH-RF, LHRH, cytokines, leptin and nitric oxide.
McCann SM; Kimura M; Walczewska A; Karanth S; Rettori V; Yu WH
Neuroimmunomodulation; 1998; 5(3-4):193-202. PubMed ID: 9730686
[TBL] [Abstract][Full Text] [Related]
40. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Steele TD; Nichols DE; Yim GK
Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
